{"id":"https://openalex.org/W2086842286","doi":"https://doi.org/10.1185/03007990903156111","title":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study","display_name":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study","publication_year":2009,"publication_date":"2009-08-04","ids":{"openalex":"https://openalex.org/W2086842286","doi":"https://doi.org/10.1185/03007990903156111","mag":"2086842286","pmid":"https://pubmed.ncbi.nlm.nih.gov/19650752"},"language":"en","primary_location":{"id":"doi:10.1185/03007990903156111","doi":"https://doi.org/10.1185/03007990903156111","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990903156111","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059098934","display_name":"Richard E. Pratley","orcid":"https://orcid.org/0000-0002-2912-1389","observed_orcids":["https://orcid.org/0000-0002-2912-1389"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard E. Pratley","raw_affiliation_strings":["University of Vermont, College of Medicine, Burlington, VT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vermont, College of Medicine, Burlington, VT, USA","institution_ids":["https://openalex.org/I111236770"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029406825","display_name":"Jane E.B. Reusch","orcid":"https://orcid.org/0000-0001-8620-1003","observed_orcids":["https://orcid.org/0000-0001-8620-1003"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane E.-B. Reusch","raw_affiliation_strings":["University of Colorado, Health Sciences Center, Denver, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Health Sciences Center, Denver, CO, USA","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011829580","display_name":"Penny R. Fleck","orcid":"https://orcid.org/0000-0003-3597-975X","observed_orcids":["https://orcid.org/0000-0003-3597-975X"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Penny R. Fleck","raw_affiliation_strings":["Takeda Global Research & Development Center, Inc., Deerfield, IL, USA","Takeda Global Research and Development Center, Inc, Deerfield, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research & Development Center, Inc., Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]},{"raw_affiliation_string":"Takeda Global Research and Development Center, Inc, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103595279","display_name":"Craig Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig A. Wilson","raw_affiliation_strings":["Takeda Global Research & Development Center, Inc., Deerfield, IL, USA","Takeda Global Research and Development Center, Inc, Deerfield, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research & Development Center, Inc., Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]},{"raw_affiliation_string":"Takeda Global Research and Development Center, Inc, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080806600","display_name":"Qais A. Mekki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qais Mekki","raw_affiliation_strings":["Takeda Global Research & Development Center, Inc., Deerfield, IL, USA","Takeda Global Research and Development Center, Inc, Deerfield, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research & Development Center, Inc., Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]},{"raw_affiliation_string":"Takeda Global Research and Development Center, Inc, Deerfield, IL, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the Alogliptin Study 009 Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"on behalf of the Alogliptin Study 009 Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5059098934"],"corresponding_institution_ids":["https://openalex.org/I111236770"],"apc_list":null,"apc_paid":null,"fwci":9.3765,"has_fulltext":false,"cited_by_count":132,"citation_normalized_percentile":{"value":0.98623976,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"25","issue":"10","first_page":"2361","last_page":"2371"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9760000109672546},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8640000224113464},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9919999837875366},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9359999895095825},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9559999704360962},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9710000157356262},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.718999981880188},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7839999794960022},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7049999833106995},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6069999933242798},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.3869999945163727},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.35600000619888306},{"id":"https://openalex.org/keywords/liver-function","display_name":"liver function","score":0.3240000009536743}],"concepts":[{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.9922740459442139},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8918547034263611},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.7962890863418579},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7554566264152527},{"id":"https://openalex.org/C2778763485","wikidata":"https://www.wikidata.org/wiki/Q419770","display_name":"Dipeptidyl peptidase-4 inhibitor","level":4,"score":0.6559907793998718},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6541116833686829},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6328770518302917},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6283103227615356},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.6117854118347168},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6003847122192383},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5242182016372681},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47737714648246765},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4745044410228729},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.46848925948143005},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.4531250298023224},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.42603427171707153},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39440664649009705},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3645226061344147},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.23736459016799927},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.17589044570922852},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.13273626565933228},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007990903156111","doi":"https://doi.org/10.1185/03007990903156111","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990903156111","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:19650752","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19650752","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W100598291","https://openalex.org/W1984588810","https://openalex.org/W2027249582","https://openalex.org/W2030207960","https://openalex.org/W2042129134","https://openalex.org/W2046766433","https://openalex.org/W2050826565","https://openalex.org/W2061865937","https://openalex.org/W2064780710","https://openalex.org/W2084403835","https://openalex.org/W2093356629","https://openalex.org/W2106154942","https://openalex.org/W2139611060","https://openalex.org/W2145335273","https://openalex.org/W2153449155","https://openalex.org/W2159205789","https://openalex.org/W2165698647","https://openalex.org/W4240449862"],"related_works":["https://openalex.org/W2061865937","https://openalex.org/W2106154942","https://openalex.org/W2141946042","https://openalex.org/W2092918268","https://openalex.org/W7100187316","https://openalex.org/W2151668968","https://openalex.org/W2353007761","https://openalex.org/W7217626693","https://openalex.org/W2234801053","https://openalex.org/W2027788348"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"evaluate":[2,292],"the":[3,293],"efficacy":[4,91],"and":[5,111,114,127,248,283,302],"safety":[6],"of":[7,116,167,223,244,268,295],"alogliptin":[8,65,68,146,176,200,235,269],"in":[9,95,106,137,191,277],"patients":[10,35,168,224,278],"with":[11,19,39,53,62,77,175,185,199,215,225,261,279],"type":[12,280],"2":[13,281],"diabetes":[14,282],"inadequately":[15],"controlled":[16],"by":[17],"therapy":[18,76,272,297],"a":[20,28,54],"thiazolidinedione":[21],"(TZD).":[22],"RESEARCH":[23],"DESIGN":[24],"AND":[25],"METHODS:":[26],"In":[27],"multicenter,":[29],"double-blind,":[30],"placebo-controlled":[31],"clinical":[32,300],"study,":[33],"493":[34],"18-80":[36],"years":[37],"old":[38],"inadequate":[40],"glycemic":[41,275],"control":[42,276],"after":[43],"stabilization":[44],"(i.e.,":[45],"glycosylated":[46],"hemoglobin":[47],"[HbA(1c)]":[48],"7.0-10.0%)":[49],"despite":[50],"ongoing":[51],"treatment":[52,61,253,263],"TZD":[55],"were":[56,193,250],"randomly":[57],"assigned":[58],"(2:2:1)":[59],"to":[60,99,270],"pioglitazone":[63,271],"plus":[64],"12.5":[66,147,177,201],"mg,":[67],"25":[69,151,181,208],"mg":[70,148,152,178,182,202,209],"or":[71,79,121,150,162,172,180,207,237],"placebo":[72,156,186,216,240],"once":[73],"daily.":[74],"Concomitant":[75],"metformin":[78],"sulfonylurea":[80],"at":[81],"prestudy":[82],"doses":[83],"was":[84,93,139,228,284],"permitted.":[85],"MAIN":[86],"OUTCOME":[87],"MEASURES:":[88],"The":[89,221,242,288],"primary":[90],"endpoint":[92],"change":[94,136],"HbA(1c)":[96,138,170],"from":[97],"baseline":[98],"Week":[100],"26.":[101],"Secondary":[102],"endpoints":[103],"included":[104],"changes":[105],"fasting":[107],"plasma":[108],"glucose":[109],"(FPG)":[110],"body":[112],"weight,":[113],"incidences":[115,243],"marked":[117,226],"hyperglycemia":[118,227],"(FPG":[119],">":[120],"=":[122,163,173,196],"200":[123],"mg/dL":[124,204,211,218],"[11.10":[125],"mmol/L])":[126,206,213],"rescue":[128],"for":[129,145,155,234],"hyperglycemia.":[130],"RESULTS:":[131],"Least":[132],"squares":[133],"(LS)":[134],"mean":[135,189],"significantly":[140,159,194,229,273],"(p":[141,160,195,230],"<":[142,161,171,231],"0.001)":[143,232],"greater":[144,198],"(-0.66%)":[149],"(-0.80%)":[153],"than":[154,184,214,239,264],"(-0.19%).":[157],"A":[158],"0.016)":[164],"larger":[165],"proportion":[166],"achieved":[169],"7%":[174],"(44.2%)":[179],"(49.2%)":[183],"(34.0%).":[187],"LS":[188],"decreases":[190],"FPG":[192],"0.003)":[197],"(-19.7":[203],"[-1.09":[205],"(-19.9":[210],"[-1.10":[212],"(-5.7":[217],"[-0.32":[219],"mmol/L]).":[220],"percentage":[222],"lower":[233],"(<":[236],"=25.0%)":[238],"(44.3%).":[241],"overall":[245],"adverse":[246],"events":[247,257],"hypoglycemia":[249],"similar":[251],"across":[252],"groups,":[254],"but":[255],"cardiac":[256],"occurred":[258],"more":[259],"often":[260],"active":[262],"placebo.":[265],"CONCLUSIONS:":[266],"Addition":[267],"improved":[274],"generally":[285],"well":[286],"tolerated.":[287],"study":[289],"did":[290],"not":[291],"effect":[294],"combination":[296],"on":[298],"long-term":[299],"outcomes":[301],"safety.":[303],"CLINICAL":[304],"TRIAL":[305],"REGISTRATION:":[306],"NCT00286494,":[307],"clinicaltrials.gov.":[308]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}